On October 6, 2025, California Governor Gavin Newsom signed AB325, a law targeting the use and distribution of certain algorithmic pricing tools. This law is part of a larger legislative trend to try to rein in algorithmic pricing. But while other bills have focused narrowly on the rental housing market and languished in state legislatures,
Antitrust Law Blog
Current Antitrust & Competition News & Regulatory Developments
Latest from Antitrust Law Blog
FTC Recommends Rollback of Anticompetitive Regulations
The Federal Trade Commission (“FTC”) has turned the antitrust lens inward, examining and recommending removal or revision of federal regulations it deems as potential barriers to entry and innovation. In a letter to the Office of Management and Budget (“OMB”) dated September 16, 2025, Chairman Andrew N. Ferguson identified more than 125 regulations that, in…
State Antitrust Enforcement Roundup: Updates to Healthcare Merger Matrix; New Potential Legislation Targeting Private Equity and Other For-Profit Entities in Healthcare
State oversight of healthcare transactions is continuing to undergo a significant transformation. As tracked in our updated Healthcare Merger Matrix, the number of states implementing or considering expanding antitrust laws targeting proposed deals continues to rise.[1] For instance, Washington and Colorado’s premerger notification laws went into effect on July 27 and August…
Trump Revokes Biden Administration’s Executive Order on Antitrust & Competition but other Biden Administration Antitrust Policy Changes Remain in Place
On August 13, 2025, President Trump revoked the Biden Administration’s 2021 Executive Order (Promoting Competition in the American Economy).…
Fishing Expedition or Legitimate Dawn Raid? The Latest on European Commission’s Cartel Enforcement and Dawn Raids from the EU’s General Court
On 9 July 2025, the General Court of the European Union delivered its judgment in Case T-188/24 Michelin, addressing the scope of the European Commission’s powers to conduct on-site inspections (so-called dawn raids) under EU competition law. The Court broadly confirmed the Commission’s powers but sided with the claimant in partially annulling the Commission’s inspection…
DOJ and FTC Host Second Session on Structural and Regulatory Impediments to Drug Competition
On July 24, 2025, the Federal Trade Commission (“FTC”) and the U.S. Department of Justice (“DOJ”) convened the second of three public listening sessions aimed at identifying barriers to drug price competition in the U.S. healthcare system. The session is part of a broader policy push under Executive Order 14273, “Lowering Drug Prices by Once…
New DOJ Antitrust Postal Whistleblower Rewards Program: A Look Under the Shiny Hood
On Tuesday, July 8, the DOJ Antitrust Division announced a first-of-its-kind Antitrust Whistleblower Rewards Program (the “Program”). But the Program’s fine print suggests it may not be as lucrative for whistleblowers as it appears at first blush.…
Cement and Concrete Admixture Price Fixing Conspiracy Allegations Not Strong Enough to Survive Motion to Dismiss
Judge Lewis Liman in the Southern District of New York recently dismissed antitrust complaints brought by direct and indirect purchasers against six major suppliers of concrete admixtures, cement additives, admixtures for mortar, and related products (“CCAs”), alleging that the suppliers conspired to fix prices.[1] Specifically, plaintiffs alleged that between 2017 and present, defendants agreed…
Red Tape Rollback: DOJ’s Anticompetitive Regulations Task Force
As we predicted before the inauguration, Trump 2.0 antitrust enforcers have shown continued support for the pro-worker, anti-tech antitrust agenda that has permeated recent antitrust enforcement through the last two administration changes. This time around, President Trump appointed competition agency leaders in Chair Ferguson at the Federal Trade Commission (FTC) and AAG Slater at the…
Major Regulatory Updates from the West Coast: New California and Washington Approaches to Healthcare Private Equity and MSO Regulation
State legislatures on the West Coast are intensifying their focus on private equity and management service organizations (MSOs) in healthcare, introducing new regulatory measures that could significantly reshape investment strategies, ownership structures, and operational matters in the healthcare space in these states. As state legislatures respond to growing concerns about the role of non-licensed entities…